Applied Clinical Trials
Biopharmaceutical sponsors should make urgent decisions now to plan for continued clinical research in the coming months.
Sharma Ramanathan Deva Devesa
Advertisement
Articles by Sharma Ramanathan Deva Devesa
Applied Clinical Trials
FDA commissioner Scott Gottlieb criticized pharmaceutical companies and clinical research organizations for being slow to adapt innovations in clinical research, claiming that the business model adopted just isn’t compatible with the kind of changes that certain innovations can enable.
Applied Clinical Trials
These seven key building blocks for success are outlined to help companies develop and implement a data-and-analytics-driven approach to clinical trial feasibility.
Advertisement
Latest Updated Articles
- How Data and Analytics Can Improve Clinical Trial Feasibility
September 24th 2018
- 4 Key Actions ClinOps Can Take Now to Avoid Disruptions
April 2nd 2020
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny
2
ACT Brief: Patient-Site Trust Barriers, Rare Disease Evidence Without Registry, and RWD Enrollment Accuracy
3
Moving Beyond Disappointing Pilots: Scaling Adoption of AI-Enablement in Drug Development
4
Trust, Technology, and the Patient-Site Relationship: Q&A with Andrea Valente, uMotif
5